Genetic Technologies Acquires EasyDNA for $5.4M
- Genetic Technologies (GTG) acquires EasyDNA for around $5.4 million in cash and scrip
- Under the contract, GTG obtains all of Belhealth’s websites, lab testing and distribution agreements associated with its EasyDNA business
- EasyDNA sells paternity, oncology and health genomics-based laboratory tests, with agreements across 12 labs in North America, Europe and Asia
- GTG says it will onboard the existing EasyDNA team, retaining the skills of all employees based in Malta and Australia
- The company says the acquisition will provide it with the foundation to grow its portfolio of serious disease tests across well-established websites in 40 countries
- The company closed flat at 0.8 cents per share
